Healthcare provider profile · identity verified

Scott Kenneth Hetzel, MD

Internal Medicine · BERLIN, WI · NPI 1417444589

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	709	197
Amlodipine Besylate	Amlodipine Besylate	527	161
Omeprazole	Omeprazole	467	137
Levothyroxine Sodium	Levothyroxine Sodium	430	110
Losartan Potassium	Losartan Potassium	378	109
Lisinopril	Lisinopril	332	92
Eliquis	Apixaban	325	71
Pravastatin Sodium	Pravastatin Sodium	285	86
Metoprolol Succinate	Metoprolol Succinate	248	84
Gabapentin	Gabapentin	235	62
Rosuvastatin Calcium	Rosuvastatin Calcium	212	70
Metformin Hcl Er	Metformin Hcl	204	67
Pantoprazole Sodium	Pantoprazole Sodium	201	66
Carvedilol	Carvedilol	192	56
Hydrochlorothiazide	Hydrochlorothiazide	185	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	159	22
Warfarin Sodium	Warfarin Sodium	153	45
Allopurinol	Allopurinol	152	41
Duloxetine Hcl	Duloxetine Hcl	149	41
Furosemide	Furosemide	149	56
Escitalopram Oxalate	Escitalopram Oxalate	148	40
Tamsulosin Hcl	Tamsulosin Hcl	139	39
Albuterol Sulfate Hfa	Albuterol Sulfate	132	67
Pregabalin	Pregabalin	128	29
Simvastatin	Simvastatin	122	40
Tramadol Hcl	Tramadol Hcl	117	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	113	32
Finasteride	Finasteride	109	32
Metoprolol Tartrate	Metoprolol Tartrate	109	37
Glipizide Er	Glipizide	105	35
Spironolactone	Spironolactone	102	32
Clopidogrel	Clopidogrel Bisulfate	93	27
Ezetimibe	Ezetimibe	91	30
Alendronate Sodium	Alendronate Sodium	83	22
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	79	21
Potassium Chloride	Potassium Chloride	79	21
Jardiance	Empagliflozin	78	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	19
Trazodone Hcl	Trazodone Hcl	76	25
Sertraline Hcl	Sertraline Hcl	71	21
Montelukast Sodium	Montelukast Sodium	69	20
Torsemide	Torsemide	69	21
Metformin Hcl	Metformin Hcl	67	20
Terazosin Hcl	Terazosin Hcl	67	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	25
Famotidine	Famotidine	62	17
Buspirone Hcl	Buspirone Hcl	59	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	18
Memantine Hcl	Memantine Hcl	56	16
Pioglitazone Hcl	Pioglitazone Hcl	51	13
Sucralfate	Sucralfate	51	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	51	14
Xarelto	Rivaroxaban	48	14
Hydralazine Hcl	Hydralazine Hcl	47	11
Synthroid	Levothyroxine Sodium	47	13
Chlorthalidone	Chlorthalidone	46	17
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	45	12
Bupropion Xl	Bupropion Hcl	45	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	43	14
Donepezil Hcl	Donepezil Hcl	40	15
Atenolol	Atenolol	39	11
Valsartan	Valsartan	39	12
Mirtazapine	Mirtazapine	38	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	18
Mounjaro	Tirzepatide	37	suppressed
Ozempic	Semaglutide	37	11
Clonidine Hcl	Clonidine Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	13
Prednisone	Prednisone	33	19
Celecoxib	Celecoxib	32	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Lorazepam	Lorazepam	30	suppressed
Meloxicam	Meloxicam	30	11
Glipizide	Glipizide	29	suppressed
Nystatin	Nystatin	29	14
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Myrbetriq	Mirabegron	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Baclofen	Baclofen	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	19
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	11
Benazepril Hcl	Benazepril Hcl	20	suppressed
Bumetanide	Bumetanide	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	11
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Cholestyramine	Cholestyramine (With Sugar)	19	suppressed
Linzess	Linaclotide	19	suppressed
Nitroglycerin	Nitroglycerin	19	13
Topiramate	Topiramate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	16
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Clotrimazole	Clotrimazole	18	11
Irbesartan	Irbesartan	18	suppressed
Dilt-Xr	Diltiazem Hcl	16	suppressed
Febuxostat	Febuxostat	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Insulin Aspart Flexpen	Insulin Aspart	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Metolazone	Metolazone	14	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Lyrica	Pregabalin	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Cefdinir	Cefdinir	11	11
Dapsone	Dapsone	11	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error